8-27469915-G-A

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_001347705.2(CHRNA2):​c.-288C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000512 in 1,614,166 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00035 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 1 hom. )

Consequence

CHRNA2
NM_001347705.2 5_prime_UTR_premature_start_codon_gain

Scores

4
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:8

Conservation

PhyloP100: 3.10

Publications

3 publications found
Variant links:
Genes affected
CHRNA2 (HGNC:1956): (cholinergic receptor nicotinic alpha 2 subunit) Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels formed by a pentameric arrangement of alpha and beta subunits to create distinct muscle and neuronal receptors. Neuronal receptors are found throughout the peripheral and central nervous system where they are involved in fast synaptic transmission. This gene encodes an alpha subunit that is widely expressed in the brain. The proposed structure for nAChR subunits is a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. Mutations in this gene cause autosomal dominant nocturnal frontal lobe epilepsy type 4. Single nucleotide polymorphisms (SNPs) in this gene have been associated with nicotine dependence. [provided by RefSeq, Nov 2009]
CHRNA2 Gene-Disease associations (from GenCC):
  • autosomal dominant nocturnal frontal lobe epilepsy 4
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial sleep-related hypermotor epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • benign familial infantile epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • epilepsy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.102101505).
BP6
Variant 8-27469915-G-A is Benign according to our data. Variant chr8-27469915-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 204979.
BS2
High AC in GnomAd4 at 53 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001347705.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA2
NM_000742.4
MANE Select
c.140C>Tp.Thr47Met
missense
Exon 3 of 7NP_000733.2Q15822-1
CHRNA2
NM_001347705.2
c.-288C>T
5_prime_UTR_premature_start_codon_gain
Exon 3 of 7NP_001334634.1
CHRNA2
NM_001347706.2
c.-333C>T
5_prime_UTR_premature_start_codon_gain
Exon 3 of 7NP_001334635.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA2
ENST00000407991.3
TSL:5 MANE Select
c.140C>Tp.Thr47Met
missense
Exon 3 of 7ENSP00000385026.1Q15822-1
CHRNA2
ENST00000523695.5
TSL:1
n.140C>T
non_coding_transcript_exon
Exon 3 of 7ENSP00000430612.1E5RJ54
CHRNA2
ENST00000240132.7
TSL:2
c.140C>Tp.Thr47Met
missense
Exon 3 of 7ENSP00000240132.2Q15822-2

Frequencies

GnomAD3 genomes
AF:
0.000355
AC:
54
AN:
152210
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000603
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000462
AC:
116
AN:
251244
AF XY:
0.000471
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000868
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000933
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000529
AC:
773
AN:
1461838
Hom.:
1
Cov.:
32
AF XY:
0.000484
AC XY:
352
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33480
American (AMR)
AF:
0.0000671
AC:
3
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.000356
AC:
19
AN:
53364
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000660
AC:
734
AN:
1112012
Other (OTH)
AF:
0.000215
AC:
13
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
57
114
171
228
285
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000348
AC:
53
AN:
152328
Hom.:
0
Cov.:
32
AF XY:
0.000309
AC XY:
23
AN XY:
74482
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41586
American (AMR)
AF:
0.000196
AC:
3
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5164
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000603
AC:
41
AN:
68028
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000599
Hom.:
0
Bravo
AF:
0.000329
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000349
AC:
3
ExAC
AF:
0.000494
AC:
60
EpiCase
AF:
0.000382
EpiControl
AF:
0.000771

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
Autosomal dominant nocturnal frontal lobe epilepsy 4 (4)
-
2
2
not provided (4)
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Benign
-0.18
T
BayesDel_noAF
Benign
-0.10
CADD
Benign
20
DANN
Benign
0.94
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.51
Eigen_PC
Benign
-0.52
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.55
T
M_CAP
Benign
0.041
D
MetaRNN
Benign
0.10
T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.0
N
PhyloP100
3.1
PrimateAI
Benign
0.39
T
PROVEAN
Benign
0.58
N
REVEL
Uncertain
0.40
Sift
Uncertain
0.026
D
Sift4G
Uncertain
0.051
T
Polyphen
0.83
P
Vest4
0.56
MVP
0.76
MPC
0.27
ClinPred
0.036
T
GERP RS
3.3
Varity_R
0.021
gMVP
0.38
Mutation Taster
=21/79
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74772771; hg19: chr8-27327432; COSMIC: COSV108053219; COSMIC: COSV108053219; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.